CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle

Elizabeth Goldmuntz1, Richard Bamford, Jayaprakash D Karkera

  • 1Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Insights

CFC1 gene mutations are linked to congenital heart defects like transposition of the great arteries and double-outlet right ventricle. This discovery reveals a shared genetic cause between these conditions and heterotaxy syndrome.

Area of Science:

  • Genetics
  • Developmental Biology
  • Cardiology

Background:

  • Heterotaxy syndrome is associated with heterozygous CFC1 mutations and congenital cardiac malformations.
  • Malposition of the great arteries is a common cardiac defect in heterotaxy syndrome.

Purpose of the Study:

  • To investigate CFC1 mutations in patients with transposition of the great arteries (TGA) and double-outlet right ventricle (DORV) without laterality defects.
  • To determine if CFC1 mutations represent a shared genetic etiology for these cardiac malformations and heterotaxy syndrome.

Main Methods:

  • Genetic analysis of the CFC1 gene in 86 patients diagnosed with TGA or DORV.
  • Comparison of mutation findings with clinical phenotypes, focusing on the absence of laterality defects.

Main Results:

  • Two disease-related CFC1 mutations were identified in the studied patient cohort.
  • This study represents the first identification of an autosomal single-gene defect responsible for TGA and DORV.

Conclusions:

  • Some cases of TGA and DORV share a common genetic etiology with heterotaxy syndrome, linked to CFC1 mutations.
  • The molecular pathway involving CFC1 is crucial for normal and abnormal cardiovascular development.
  • CFC1 mutations can cause congenital heart defects even in the absence of laterality defects.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...